Related Experiment Videos
[Familial hypertrophic cardiomyopathy]
M Wróblewska-Kałuzewska1, W Ozimek, M Pleskot
1Kliniki Kardiologii Wieku Dzieciecego A. M. w Warszawie.
Insights
Hypertrophic cardiomyopathy diagnosis was confirmed in 5 of 8 family members. Clinical symptoms did not correlate with echocardiographic hypertrophy, which was most severe in younger patients, suggesting genetic factors.
Area of Science:
- Cardiology
- Genetics
- Medical Diagnostics
Background:
- Hypertrophic cardiomyopathy (HCM) is a significant inherited cardiac condition.
- Understanding the genetic basis and clinical presentation of familial HCM is crucial for effective management.
Observation:
- A family screening study identified hypertrophic cardiomyopathy in 5 out of 8 members.
- Clinical symptoms showed a lack of correlation with echocardiographic findings of cardiac hypertrophy.
Findings:
- The most pronounced patterns of cardiac hypertrophy were observed in the youngest patients within the family.
- This suggests a potential link between increased gene expression/penetrance and the severity of hypertrophy in younger individuals.
Implications:
- Family screening is essential for diagnosing and managing inherited hypertrophic cardiomyopathy.
- Further research into gene expression and penetrance in familial HCM is warranted.
Abstract:
Investigating the family consisted of 8 members authors confirmed the diagnosis of hypertrophic cardiomyopathy in 5 cases. Secondly clinical features and echocardiographic data were compared. The clinical symptoms were not proportional to the pattern of hypertrophy revealed by echocardiography. The most significant pattern of hypertrophy was registered in youngest patients most likely due to increased expression and penetration of responsible genes. Considering cardiomyopathy as an inherited disease authors find family screening as a key in understanding and management of the disease.